Search filters

List of works by Giandomenico Roviello

A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial

scientific article published on 21 June 2016

A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers

scientific article

A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report

scientific article published on 30 October 2013

A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development

scientific article published on 21 August 2019

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer

scientific article published on 01 April 2014

Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival

scientific article

Acute Massive and Submassive Pulmonary Embolism: Preliminary Validation of Aspiration Mechanical Thrombectomy in Patients with Contraindications to Thrombolysis

scientific article published on 06 July 2018

Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?

scientific article published in July 2018

Advances in systemic therapy for metastatic breast cancer: future perspectives.

scientific article published on 19 May 2017

An exceptional overall survival using bevacizumab beyond progression in a patient with non-small cell lung cancer.

scientific article

Angiogenesis inhibitors in gastric and gastroesophageal junction cancer

scientific article published on 02 September 2015

Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis

scientific article published on 25 June 2019

Apatinib for the treatment of gastric cancer

scientific article published on 15 July 2016

Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer.

scientific article

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

scientific article published on 8 April 2017

Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer.

scientific article

Avelumab in gastric cancer

scientific article published on 06 May 2019

Bevacizumab and weekly docetaxel in patients with metastatic castrate-resistant prostate cancer previously exposed to docetaxel

scientific article

Bevacizumab in small cell lung cancer

scientific article published on September 2017

Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?

scientific article published on 01 September 2019

Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II study

scientific article published on September 2015

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

scientific article

Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience.

scientific article published on 18 May 2015

Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone

article

Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?

scientific article

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

scientific article published on 15 July 2018

Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer

scientific article published on 07 August 2018

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer

scientific article published on 17 March 2016

Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment

scientific article published on 19 June 2020

Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study.

scientific article

Effects of abiraterone acetate on chronic kidney disease in 2 patients with metastatic castration-resistant prostate cancer

scientific article published on December 2014

Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trials

scientific article published on 25 April 2019

Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma

scientific article

Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis

scientific article

Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives.

scientific article published in July 2017

Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence

scientific article

FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer

scientific article published on 19 October 2020

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

scientific article published on 06 November 2020

How to optimize the sequential use of novel therapeutics in metastatic prostate cancer patients? Response should be found in prostate cancer tissue

scientific article published on 30 May 2014

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

scientific article published on 10 January 2020

Immunotherapy‑based combinations versus standard first‑line and hypothyroidism risk

scientific article published on 20 April 2020

Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials

scientific article published on 27 February 2016

Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies Before and After Chemotherapy

scientific article published on 08 January 2019

Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis

scientific article published on 28 July 2017

Is it time for everolimus-based combination in castration-resistant prostate cancer?

scientific article published on 2 June 2016

Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trials.

scientific article

Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?

scientific article published on January 2017

Is the Gleason score the driver for the treatment decision-making of patients with castration-resistant prostate cancer in the new era of the anti-androgenic therapies?

scientific article

Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis

scientific article published on 31 January 2018

Is there still a place for docetaxel rechallenge in prostate cancer?

scientific article published on October 2015

Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?

scientific article published on 01 June 2019

Isolated Testicular Metastasis from Prostate Cancer.

scientific article published on 14 August 2017

Lenvatinib for the treatment of renal cell carcinoma.

scientific article published on 2 May 2018

Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis.

scientific article published on 29 August 2017

Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer

scientific article published on 26 March 2015

Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer

scientific article

Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experience

scientific article published on 17 July 2018

Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives

scientific article

Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer

scientific article published on 11 June 2019

Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma

scientific article published on 24 July 2017

Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient

scientific article

New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials

scientific article published on 29 October 2016

New-Generation Hormone Therapies in Nonmetastatic Castration-Resistant Prostate Cancer: Why, Who, When

scientific article published on 06 February 2019

No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.

scientific article

No clear evidence of a clinical benefit of a sequential therapy regimen with abiraterone acetate and enzalutamide

scientific article

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights

scientific article published on 04 July 2019

Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: an evolving issue

scientific article published on 01 April 2019

PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy

scientific article published on 5 July 2017

PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials

scientific article published on 07 September 2014

Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223

scientific article published on 17 December 2018

Pertuzumab therapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer

scientific article published on 11 September 2018

Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel

scientific article published on 01 August 2019

Radiotherapy after prostatectomy in high‑risk prostate cancer

scientific article published on 30 March 2020

Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?

scientific article published on 16 March 2019

Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press

scientific article published on 16 August 2016

Re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate C

scientific article

Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience

scientific article

Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies

scientific article

Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?

scientific article published on 05 August 2019

Risk of hypertension with ramucirumab-based therapy in solid tumors: data from a literature based meta-analysis.

scientific article

Role of ATP-binding cassette transporters in cancer initiation and progression

scientific article published on 11 August 2019

Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate.

scientific article published on 17 June 2015

Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials

scientific article published on 15 October 2019

Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis.

scientific article published on 14 July 2016

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials

scientific article

Safety of sorafenib therapy in elderly adults with advanced hepatocellular carcinoma

scientific article published on 01 November 2014

Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II study

scientific article

Targeted Therapies for Prostate Cancer

scientific article published on 07 May 2015

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials

scientific article

The distinctive nature of adenocarcinoma of the lung

scientific article

The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer

scientific article published on 28 January 2019

The latest developments in biomarkers predicting response to immunotherapy

scientific article published in 2022

The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer

scientific article published on 11 December 2019

The prognostic value of PI3K mutational status in breast cancer: a meta-analysis

scientific article published on 18 January 2018

The promising role of monoclonal antibodies for gastric cancer treatment

scientific article published on 01 March 2019

The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials.

scientific article published on 24 February 2017

The third line of treatment for metastatic prostate cancer patients: Option or strategy?

scientific article published on 21 May 2015

Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.

scientific article

Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer

scientific article

Time for a revision on the role of PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatment for patients with metastatic hormone-refractory prostate cancer.

scientific article published in July 2013

Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience

scientific article published on September 2015

Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status

scientific article

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

scientific article published on April 2017

Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma

scientific article published on 06 March 2019

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer.

scientific article

c-Met targeting in advanced gastric cancer: An open challenge.

scientific article published on 03 June 2015

Paulina is supported by:

About Paulina

Help